PG icon

Procter & Gamble

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 32.2%
Negative

Neutral
Business Wire
17 hours ago
P&G Recommends Stockholders Reject Mini-Tender Offer by Potemkin Limited
CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) today announced that it has been notified of an unsolicited “mini-tender” offer by Potemkin Limited (Potemkin) to purchase up to 50,000 shares (or a greater amount as outlined in the offer documentation) of the Company's common stock at a price of $100.00 per share. The $100.00 per share offer price represents an approximately 31 percent discount to the closing price of $145.52 on December 18, 2025, the last trading day pri.
P&G Recommends Stockholders Reject Mini-Tender Offer by Potemkin Limited
Neutral
Business Wire
yesterday
P&G Declares Quarterly Dividend, January 2026
CINCINNATI--(BUSINESS WIRE)--The Board of Directors of The Procter & Gamble Company (NYSE:PG) declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2026 to Common Stock shareowners of record at the close of business on January 23, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareowners of record at the start of business o.
P&G Declares Quarterly Dividend, January 2026
Neutral
Zacks Investment Research
yesterday
Is Procter & Gamble's 4% Sales Growth Target at Risk From Tariff Woes?
Tariff costs test PG's plan for upto 4% organic sales growth, as pricing limits and slower consumption tighten execution risks.
Is Procter & Gamble's 4% Sales Growth Target at Risk From Tariff Woes?
Neutral
Zacks Investment Research
2 days ago
Procter & Gamble (PG) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, Procter & Gamble (PG) closed at $143.46, indicating a +1.12% shift from the previous trading day.
Procter & Gamble (PG) Exceeds Market Returns: Some Facts to Consider
Positive
Zacks Investment Research
2 days ago
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
Positive
Seeking Alpha
3 days ago
Dividend Income: Lanny's November 2025 Summary
In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.
Dividend Income: Lanny's November 2025 Summary
Positive
Forbes
3 days ago
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips
The Dow Jones Industrial Average itself yields modestly, but the Dogs of the Dow 2026 pack more dividend bite. The index's top payers dish up to 6.8%.
The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips
Positive
24/7 Wall Street
4 days ago
Can the Dogs of the Dow Really Beat the Magnificent 7 in 2026?
Even suggesting that the Dogs of the Dow could outperform the Magnificent 7 in 2026 seems ludicrous.
Can the Dogs of the Dow Really Beat the Magnificent 7 in 2026?
Positive
Seeking Alpha
4 days ago
January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its single share price. Analyst projections suggest the top ten Dow Dogs could deliver an average 23.55% net gain by January 2027, with varying risk profiles. Yield-based strategies favor underdogs; price drops or dividend hikes could bring more Dow Dogs into fair-value territory for income-focused investors.
January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy
Positive
Seeking Alpha
5 days ago
Procter & Gamble: The Market Is Wrong - It's Time To Buy This Compounder (Rating Upgrade)
Procter & Gamble (PG) offers a compelling buy opportunity as a high-quality, low-beta compounder at a multi-year valuation low. PG has delivered consistent top- and bottom-line growth, with TTM revenue rising from $73B to $84B and TTM profits growing from $13.9B to $16.7B over the last five years. Management has reduced share count by 7% since 2021 through disciplined buybacks, supporting EPS growth and long-term shareholder value.
Procter & Gamble: The Market Is Wrong - It's Time To Buy This Compounder (Rating Upgrade)